Literature DB >> 34587332

Time in range in relation to amputation and all-cause mortality in hospitalised patients with diabetic foot ulcers.

Puguang Xie1, Bo Deng1, Xi Zhang1, Yuyao Li1, Chenzhen Du1, Shunli Rui1, Wu Deng2, Johnson Boey3, David G Armstrong4, Yu Ma1, Wuquan Deng1.   

Abstract

AIMS: The aim of this study was to evaluate the association of time in range (TIR) with amputation and all-cause mortality in hospitalised patients with diabetic foot ulcers (DFUs).
MATERIALS AND METHODS: A retrospective analysis was performed on 303 hospitalised patients with DFUs. During hospitalisation, TIR, mean blood glucose (MBG), coefficient of variation (CV), time above range (TAR) and time below range (TBR) of patients were determined from seven-point blood glucose profiles. Participants were grouped based on their clinical outcomes (i.e., amputation and death). Logistic regression was employed to analyse the association of TIR with amputation and all-cause mortality of inpatients with DFUs.
RESULTS: Among the 303 enrolled patients, 50 (16.5%) had undergone amputation whereas seven (2.3%) were deceased. Blood glucose was determined in 41,012 samples obtained from all participants. Patients who underwent amputation had significantly lower TIR and higher MBG, CV, level 2 TAR and level 1 TBR whereas deceased patients had significantly lower TIR and higher MBG and level 2 TAR. Both amputation and all-cause mortality rate declined with an increase in TIR quartiles. Logistic regression showed association of TIR with amputation (p = 0.034) and all-cause mortality (p = 0.013) after controlling for 15 confounders. This association was similarly significant in all-cause mortality after further adjustment for CV (p = 0.022) and level 1 TBR (p = 0.021), respectively.
CONCLUSIONS: TIR is inversely associated with amputation and all-cause mortality of hospitalised patients with DFUs. Further prospective studies are warranted to establish a causal relationship between TIR and clinical outcomes in patients with DFUs.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  all-cause mortality; amputation; diabetic foot; time in range

Mesh:

Substances:

Year:  2021        PMID: 34587332     DOI: 10.1002/dmrr.3498

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   8.128


  5 in total

1.  Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation.

Authors:  Xueyao Yin; WeiFen Zhu; Chao Liu; Huilan Yao; Jiaxing You; Yixin Chen; Xiaofang Ying; Lin Li
Journal:  Ther Adv Endocrinol Metab       Date:  2022-05-18       Impact factor: 4.435

Review 2.  The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review.

Authors:  Evanthia Gouveri; Nikolaos Papanas
Journal:  Diabetes Ther       Date:  2022-04-08       Impact factor: 3.595

3.  The amputation and mortality of inpatients with diabetic foot ulceration in the COVID-19 pandemic and postpandemic era: A machine learning study.

Authors:  Chenzhen Du; Yuyao Li; Puguang Xie; Xi Zhang; Bo Deng; Guixue Wang; Youqiang Hu; Min Wang; Wu Deng; David G Armstrong; Yu Ma; Wuquan Deng
Journal:  Int Wound J       Date:  2021-11-24       Impact factor: 3.099

4.  Relationship between cognitive function in individuals with diabetic foot ulcer and mortality.

Authors:  Yael Sela; Keren Grinberg; Tali Cukierman-Yaffe; Rachel Natovich
Journal:  Diabetol Metab Syndr       Date:  2022-09-19       Impact factor: 5.395

Review 5.  The role of allogeneic platelet-rich plasma in patients with diabetic foot ulcer: Current perspectives and future challenges.

Authors:  Min He; Tianyi Chen; Yuhuan Lv; Peiyang Song; Bo Deng; Xuewen Guo; Shunli Rui; Johnson Boey; David G Armstrong; Yu Ma; Wuquan Deng
Journal:  Front Bioeng Biotechnol       Date:  2022-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.